Skip to main content
. Author manuscript; available in PMC: 2016 Oct 12.
Published in final edited form as: Transfusion. 2013 Apr 29;53(10 Pt 2):2459–2466. doi: 10.1111/trf.12218

TABLE 2.

Proportion of replicate assays that were reactive on 29 Ultrio initially nonreactive HBsAg carrier samples and individual results on four samples with significantly different reactivity rates between the Ultrio Plus and TaqScreen assays

Sample copies/mL Ultrio Ultrio Plus TaqScreen p value*
1 1.6 0/12 (0) 1/12 (8) 4/6 (67) 0.009
2 4.6 3/12 (25) 10/12 (83) 2/6 (33) 0.034
3 1.2 0/12 (0) 1/12 (8) 3/6 (50) 0.045
4 1.0 2/12 (17) 6/12 (50) 0/6 (0) 0.003
5–29 0.3–240 Not shown Not shown Not shown NS
All (n = 29) 0.3–240 80/348 (23) 225/348 (65) 125/174 (72) 0.0997
*

p value for comparison Ultrio Plus versus TaqScreen.

Data are reported as number (%).

p < 0.0001.

NS = not significant.

[Correction added after online publication 29-Apr-2013: Footnotes have been updated.]